Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin https://t.co/iv3XXoppxx https://t.co/28ls4ujeZr
RT @FINDdx: New paper: “Xpert MTB/XDR for detection of pulmonary #tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide,…
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin https://t.co/X2XUaIGhyU https://t.co/orO2r8Eprr
RT @sgschumacher: OUT NOW: Cochrane review summarizing the data from our @FIND study of the Xpert MTB/XDR assay and a second multicenter st…
RT @sgschumacher: OUT NOW: Cochrane review summarizing the data from our @FIND study of the Xpert MTB/XDR assay and a second multicenter st…
RT @FINDdx: New paper: “Xpert MTB/XDR for detection of pulmonary #tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide,…
RT @FINDdx: New paper: “Xpert MTB/XDR for detection of pulmonary #tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide,…
RT @FINDdx: New paper: “Xpert MTB/XDR for detection of pulmonary #tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide,…
RT @FINDdx: New paper: “Xpert MTB/XDR for detection of pulmonary #tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide,…
RT @sgschumacher: OUT NOW: Cochrane review summarizing the data from our @FIND study of the Xpert MTB/XDR assay and a second multicenter st…
RT @FINDdx: New paper: “Xpert MTB/XDR for detection of pulmonary #tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide,…
RT @FINDdx: New paper: “Xpert MTB/XDR for detection of pulmonary #tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide,…
New paper: “Xpert MTB/XDR for detection of pulmonary #tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.” Co-authored by FIND’s Senior Scientist, Margaretha De Vos. https://t.co/oB3L5O6sfM @cochranecollab @sgschumacher h
#Xpert #MTB/#XDR, a rapid test for resistance to #tuberculosis drugs https://t.co/eD2CBHurEi
RT @CeroMuertesxTB: Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs | Systematic review Cochrane Xpert MTB/XDR provides ac…
RT @CeroMuertesxTB: Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs | Systematic review Cochrane Xpert MTB/XDR provides ac…
RT @CeroMuertesxTB: Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs | Systematic review Cochrane Xpert MTB/XDR provides ac…
RT @sgschumacher: OUT NOW: Cochrane review summarizing the data from our @FIND study of the Xpert MTB/XDR assay and a second multicenter st…
OUT NOW: Cochrane review summarizing the data from our @FIND study of the Xpert MTB/XDR assay and a second multicenter study: https://t.co/CcMXhlIpsT
RT @CeroMuertesxTB: Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs | Systematic review Cochrane Xpert MTB/XDR provides ac…
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin https://t.co/zIHIWzp8wM https://t.co/5jJrhS428T
RT @CeroMuertesxTB: Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs | Systematic review Cochrane Xpert MTB/XDR provides ac…
RT @CeroMuertesxTB: Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs | Systematic review Cochrane Xpert MTB/XDR provides ac…
Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs | Systematic review Cochrane Xpert MTB/XDR provides accurate results for detection of isoniazid and fluoroquinolone resistance and can assist with selection of an optimised treatment regimen.